EIF4EBP1 and acute myeloid leukemia: In contrast to our published findings in AML, PegC treatment of PDAC cell lines did not significantly alter 4EBP1 or eIF4E phosphorylation, suggesting that the observed inhibition of protein synthesis was independent of mTOR-regulated cap-dependent translation mechanisms (Supplemental Fig. S3).